These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 10091395

  • 1. Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion.
    España F, Villa P, Mira Y, Grancha S, Royo M, Estellés A, Vayá A, Aznar J.
    Haematologica; 1999 Jan; 84(1):80-4. PubMed ID: 10091395
    [Abstract] [Full Text] [Related]

  • 2. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Jan; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 3. Thrombophilic dimension of recurrent fetal loss in Indian patients.
    Vora S, Shetty S, Ghosh K.
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):581-4. PubMed ID: 18685442
    [Abstract] [Full Text] [Related]

  • 4. Antiphospholipid antibodies.
    Triplett DA.
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):726-30. PubMed ID: 16258476
    [Abstract] [Full Text] [Related]

  • 5. [Thrombophilias associated with cerebral venous thrombosis].
    Schlück E, Rodier G, Derouiche F, Bronner P, Boulay C, Courtois S, Cohen E.
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):543-52. PubMed ID: 12072822
    [Abstract] [Full Text] [Related]

  • 6. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome.
    Bladt V, Steengaard-Pedersen K, Poulsen LH, Petersen OB, Laursen B, d'Amore F.
    Eur J Haematol; 2004 Dec; 73(6):437-40. PubMed ID: 15522067
    [Abstract] [Full Text] [Related]

  • 7. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L.
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [Abstract] [Full Text] [Related]

  • 8. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M.
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [Abstract] [Full Text] [Related]

  • 9. [Antiphospholipid syndrome].
    Yuste JR, Beloqui O, De la Peña A, Prieto J.
    Rev Med Univ Navarra; 1998 Apr; 42(4):194-207. PubMed ID: 10420931
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune thrombophilic syndromes.
    Greaves M.
    Haematologica; 1999 Jun; 84 Suppl EHA-4():32-5. PubMed ID: 10907462
    [No Abstract] [Full Text] [Related]

  • 11. Association of primary antiphospholipid syndrome with inherited activated protein C resistance.
    Picillo U, De Lucia D, Palatiello E, Scuotto A, Marcialis MR, Pezzella S, Tirri G.
    J Rheumatol; 1998 Jun; 25(6):1232-4. PubMed ID: 9632093
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibodies, hypercoagulability and thrombosis.
    Violi F, Ferro D, Quintarelli C.
    Haematologica; 1995 Jun; 80(2 Suppl):131-5. PubMed ID: 7628766
    [No Abstract] [Full Text] [Related]

  • 13. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH, Triplett DA.
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [Abstract] [Full Text] [Related]

  • 14. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA, Cervera R, Merrill JT, Erkan D.
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [Abstract] [Full Text] [Related]

  • 15. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
    Greaves M.
    Haemostasis; 2000 Apr; 30 Suppl 2():16-25. PubMed ID: 11251337
    [Abstract] [Full Text] [Related]

  • 16. [Frequency of antiphospholipid antibodies and Leiden mutation of hemostasis Factor V in unexplained recurrent fetal and embryo loss].
    Boianovski B, Ruseva M, Ganev V, Karag'ozova Zh, Mladenova A, Nikolov K, Baleva M, Dimitrova V, Chernev T, Ivanov S.
    Akush Ginekol (Sofiia); 2001 Apr; 40(3):11-4. PubMed ID: 11785358
    [Abstract] [Full Text] [Related]

  • 17. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS.
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [Abstract] [Full Text] [Related]

  • 18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T.
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [Abstract] [Full Text] [Related]

  • 20. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
    Siemens HJ, Gutsche S, Brückner S, Bucsky P, Katus HA.
    Thromb Res; 2000 May 15; 98(4):241-7. PubMed ID: 10822070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.